MORGANTOWN, W.Va.--(BUSINESS WIRE)--Infinity Natural Resources, Inc. (“Infinity”) announced today the pricing of its initial public offering of 13,250,000 shares of Class A common stock, par value ...
– Infinity Previously Announced Definitive Merger Agreement with MEI Pharma to Advance Three Promising Clinical Oncology Candidates – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. ...
Both Vicom Infinity and Infinity Systems Software will join Vicom Computer Services, A Converge Company, as part of Converge's portfolio of companies. Vicom Infinity, a world-class IBM mainframe ...
Infinity's patented air-independent UUV fuel-cell systems support extended mission operations before refueling. This provides major advantages in the form of substantial cost savings for extended ...
MORGANTOWN, W. Va.--(BUSINESS WIRE)-- Infinity Natural Resources, Inc. (“Infinity”) (NYSE: INR) announced today that Infinity President and CEO Zack Arnold and EVP and CFO David Sproule will be joined ...
TEL AVIV, ISRAEL--(Marketwired - Feb 3, 2014) - Infinity Augmented Reality, Inc. ("Infinity Augmented Reality" or "Infinity AR") (OTCQB: ALSO), a leading innovator in augmented reality technology, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that the company amended its development and license agreement with Millennium: The Takeda Oncology ...
Infinity Retains All U.S. Rights; Mundipharma Receives Ex-U.S. Commercialization Rights to All Oncology Products Under Alliance Infinity to Receive Up to $75 Million Equity Investment, Access to $50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results